Prognostic Significance of Serum Carcinoembryonic Antigen Normalization on Survival in Rectal Cancer Treated with Preoperative Chemoradiation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose The purpose of this retrospective study was to identify factors predictive of survival in rectal cancer patients who received surgery with curative intent after preoperative chemoradiotherapy (CRT). Materials and Methods Between July 1996 and June 2010, 104 patients underwent surgery for rectal cancer after preoperative CRT. The median dose of radiotherapy was 50.4 Gy (range, 43.2to 54.4 Gy) for 6 weeks. Chemotherapy was a bolus injection of 5-fluorouracil and leucovorin for the first and last week of radiotherapy (n=84, 77.1%) or capecitabine administered daily during radiotherapy (n=17, 16.3%). Low anterior resection (n=86,82.7%) or abdominoperineal resection (n=18, 17.3%) was performed at a median 47days from the end of radiotherapy, and four cycles of adjuvant chemotherapy was administered. The serum carcinoembryonic antigen (CEA) level was checked at initial diagnosis and just before surgery. Results After a median follow-up of 48 months (range, 9 to 174 months), 5-year disease free survival (DFS) was 74.5% and 5-year overall survival (OS) was 86.4%. Down staging of T diagnoses occurred in 32 patients (30.8%) and of N diagnoses in 40 patients (38.5%). The CEA change from initial diagnosis to pre-surgery (high-high vs. highnormal vs. normal-normal) was a statistically significant prognostic factor for DFS (p=0.012), OS (p=0.002), and distant metastasis free survival (p=0.018) in a multivariate analysis. Conclusion Patients who achieve normal CEA level by the time of surgery have a more favorable outcome than those who retain a high CEA level after preoperative CRT. The normalization of CEA levels can provide important information about the prognosis in rectal cancer treatment.
Abstract
Purpose The purpose of this retrospective study was to identify factors predictive of survival in rectal cancer patients who received surgery with curative intent after preoperative chemoradiotherapy (CRT). Materials and Methods Between July 1996 and June 2010, 104 patients underwent surgery for rectal cancer after preoperative CRT. The median dose of radiotherapy was 50.4 Gy (range, 43.2to 54.4 Gy) for 6 weeks. Chemotherapy was a bolus injection of 5-fluorouracil and leucovorin for the first and last week of radiotherapy (n=84, 77.1%) or capecitabine administered daily during radiotherapy (n=17, 16.3%). Low anterior resection (n=86,82.7%) or abdominoperineal resection (n=18, 17.3%) was performed at a median 47days from the end of radiotherapy, and four cycles of adjuvant chemotherapy was administered. The serum carcinoembryonic antigen (CEA) level was checked at initial diagnosis and just before surgery. Results After a median follow-up of 48 months (range, 9 to 174 months), 5-year disease free survival (DFS) was 74.5% and 5-year overall survival (OS) was 86.4%. Down staging of T diagnoses occurred in 32 patients (30.8%) and of N diagnoses in 40 patients (38.5%). The CEA change from initial diagnosis to pre-surgery (high-high vs. highnormal vs. normal-normal) was a statistically significant prognostic factor for DFS (p=0.012), OS (p=0.002), and distant metastasis free survival (p=0.018) in a multivariate analysis. Conclusion Patients who achieve normal CEA level by the time of surgery have a more favorable outcome than those who retain a high CEA level after preoperative CRT. The normalization of CEA levels can provide important information about the prognosis in rectal cancer treatment.
참고문헌 (25)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008", Cancer Research and Treatment, 43(1), pp.1~11 (2011), 대한암학회
- Sauer R, "Preoperative versus postoperative chemoradiotherapy for rectal cancer", N Engl J Med, 351, pp.1731~1740 (2004)
- Bosset JF, "Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results: EORTC 22921", J Clin Oncol, 23, pp.5620~5627 (2005)
- Bosset JF, "Chemotherapy with preoperative radiotherapy in rectal cancer", N Engl J Med, 355, pp.1114~1123 (2006)
- Bujko K, "Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy", Radiother Oncol, 72, pp.15~24 (2004)
- Gerard JP, "Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203", J Clin Oncol, 24, pp.4620~4625 (2006)
- Lim SB, "Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers", Ann Surg, 248, pp.243~251 (2008)
- Wong RK, "Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma", Cochrane Database Syst Rev, pp.CD002102~ (2007)
- Chen CC, "Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer", J Surg Res, 124, pp.169~174 (2005)
- Takagawa R, "Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resec- tion of colorectal cancer", Ann Surg Oncol, 15, pp.3433~3439 (2008)
- Secco GB, "Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial", Eur J Surg Oncol, 28, pp.418~423 (2002)
- Huh JW, "Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer", J Surg Oncol, 101, pp.396~400 (2010)
- Moureau-Zabotto L, "Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cance", Int J Radiat Oncol Biol Phys, 80, pp.483~491 (2011)
- Farnault B, "Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival", Cancer Radiother, 15, pp.279~286 (2011)
- Das P, "Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer", Cancer, 109, pp.1750~1755 (2007)
- Park YA, "Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer", J Surg Oncol, 93, pp.145~150 (2006)
- Thomas SN, "Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow", J Biol Chem, 283, pp.15647~15655 (2008)
- Thomas SN, "Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics", Biorheology, 46, pp.207~225 (2009)
- Lee JW, "Serum carcinoembryonic antigen is associated with metabolic syndrome in female Korean non-smokers", Clin Chim Acta, 412, pp.527~530 (2011)
- Jang NY, "The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer", Dis Colon Rectum, 54, pp.245~252 (2011)
- Kim CW, "Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection", Ann Surg Oncol, 18, pp.3271~3277 (2011)
- Wiratkapun S, "High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study", Dis Colon Rectum, 44, pp.231~235 (2001)
- Lin JK, "Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer", Int J Colorectal Dis, 26, pp.1135~1141 (2011)
- Kim JY, "Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels", Ann Surg Oncol, 16, pp.2771~2778 (2009)
- Ha YH, "Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer", Ann Surg, 252, pp.336~340 (2010)